Leadership
Kyowa Kirin’s first non-Japanese president accelerates a global transformation. Aviv Regev pioneers AI-driven “Lab-in-the-Loop” at Genentech, transforming drug discovery and improving patient-focused therapeutic development.
The Japanese pharma specialist has embarked on an ambitious journey to become a global specialty pharmaceutical company, driven by its first non-Japanese president at the helm.
Abivax reflects on a transformative year marked by landmark clinical success and ambitious plans for the future.
Aviv Regev is betting AI-driven drug discovery can transform Genentech's pipeline, with early wins validating her computational biology approach to pharmaceutical R&D.
Resmed’s CMO Carlos Nunez discusses the sleep giant’s continued push from medtech into healthtech and its efforts to fix what he calls a “broken pathway” to diagnosis and treatment for millions with undetected sleep apnea.